Project
CORBUS: Lenabasum bei diffuser systemischer Sklerose
Aborted ยท 2018 until 2021
Hutz Carina Liane, Bartz-Batliner Mira, Rubbert-Roth Andrea, Neumann Thomas
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2018
End Date
2021
Financing
Industry
Keywords
Lenabasum, diffuse kutane systemische Sklerose
Brief description/objective
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis